References
- Lipton RB, Bigal ME, Diamond M, et al. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 2007;68:343-9
- Lipton RB, Stewart WF, Diamond S, et al. Prevalence and burden of migraine in the United States: data from the American Migraine II Study. Headache 2001;41:646-57
- Headache Classification Committee of the International Headache Society. The international classification of headache disorders. 2nd edn. Cephalalgia 2004;24(1 Suppl):9-160
- Stewart WF, Wood GC, Manack A, et al. Employment and work impact of chronic migraine and episodic migraine. J Occup Environ Med 2010;52:8-14
- Hazard E, Munakata J, Bigal ME, et al. The burden of migraine in the United States: current and emerging perspectives on disease management and economic analysis. Value Health 2009;12:55-64
- Rapoport AM, Freitag F, Pearlman SH. Innovative delivery systems for migraine: the clinical utility of a transdermal patch for the acute treatment of migraine. CNS Drugs 2010;24:929-40
- Silberstein SD. Migraine symptoms: results of a survey of self-reported migraineurs. Headache 1995;35:387-96
- Winner P, Rothner AD, Putnam DG, et al. Demographic and migraine characteristics of adolescents with migraine: Glaxo Wellcome clinical trials’ database. Headache 2003;43:451-7
- Kelman L, Tanis D. The relationship between migraine pain and other associated symptoms. Cephalalgia 2006;26:548-53
- Diener HC, Ferrari M, Hansbach H, et al. Predicting the response to sumatriptan: the Sumatriptan Naratriptan Aggregate Patient Database. Neurology 2004;63:520-4
- Diener HC, Dodick DW, Goadsby PJ, et al. Identification of negative predictors of pain-free response to triptans: analysis of the eletriptan database. Cephalalgia 2008;28:35-40
- Holroyd KA, Drew JB, Cottrell CK, et al. Impaired functioning and quality of life in severe migraine: the role of catastrophizing and associated symptoms. Cephalalgia 2007;27:1156-65
- Tkachuk GA, Cottrell CK, Gibson JS, et al. Factors associated with migraine-related quality of life and disability in adolescents: a preliminary investigation. Headache 2003;43:950-9
- National Headache Foundation. Migraine patient survey. 2010. Available at http://www.headaches.org/NHF_Programs/NHF_Web_Surveys [last accessed 27 November 2010] (available online)
- Valade D. Early treatment of acute migraine: new evidence of benefits. Cephalalgia 2009; 29(3 Suppl):15-21
- Lipton RB, Buse DC, Saiers J, et al. Frequency and burden of headache-related nausea: results from the American Migraine Prevalence and Prevention (AMPP) Study. Headache 2013;53:93-103
- Stewart WF, Lipton RB, Celentano DD, et al. Prevalence of migraine headache in the United States: relation to age, income, race, and other sociodemographic factors. JAMA 1992;267:64-70
- Lipton RB, Diamond S, Reed M, et al. Migraine diagnosis and treatment: results from the American Migraine Study II. Headache 2001;41:638-45
- Diamond S, Bigal ME, Silberstein S, et al. Patterns of diagnosis and acute and preventive treatment for migraine in the United States: results from the American Migraine Prevalence and Prevention Study. Headache 2007;47:355-63
- Buse D, Manack A, Fanning K, et al. Chronic migraine, prevalence, disability and sociodemographic factors: results from the American Migraine Prevalence and Prevention Study. Headache 2012;52:1456-70
- Serrano D, Buse DC, Reed ML, et al. Development of the Migraine Symptom Severity Scale (MiSSS) Score: a latent variable model for migraine definition. Headache 2010;50:40
- Physician’s Fee and Coding Guide 2010. Atlanta, GA: MAG Mutual Healthcare Solutions, Inc.
- CMS/Centers for Medicare and Medicaid Services. Physician fee schedule. 2010. http://www.cms.gov/apps/physician-fee-schedule/. Accessed February 2010 (available online)
- Liebenstein M, Bigal M, Sheftell F, Tepper S, Rapoport A, Lipton R. Validation of the chronic daily headache questionnaire (CDH-Q). Headache 2007;47:760-1